
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| ELAVIL | AstraZeneca | N-012703 DISCN | 1982-01-01 | 6 products, RLD |
| ELAVIL | AstraZeneca | N-012704 DISCN | 1982-01-01 | 1 products |
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| TRIAVIL 2-25 | New River Pharmaceuticals | N-014715 DISCN | 1982-01-01 | 1 products |
| TRIAVIL 4-10 | New River Pharmaceuticals | N-014715 DISCN | 1982-01-01 | 1 products |
| TRIAVIL 2-10 | New River Pharmaceuticals | N-014715 DISCN | 1982-01-01 | 1 products |
| TRIAVIL 4-25 | New River Pharmaceuticals | N-014715 DISCN | 1982-01-01 | 1 products |
| TRIAVIL 4-50 | New River Pharmaceuticals | N-014715 DISCN | 1982-01-01 | 1 products |
| ETRAFON-A | Merck & Co | N-014713 DISCN | 1982-01-01 | 1 products |
| ETRAFON 2-25 | Merck & Co | N-014713 DISCN | 1982-01-01 | 1 products |
| ETRAFON-FORTE | Merck & Co | N-014713 DISCN | 1982-01-01 | 1 products |
| ETRAFON 2-10 | Merck & Co | N-014713 DISCN | 1982-01-01 | 1 products |
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| LIMBITROL | Chartwell Pharmaceuticals | N-016949 DISCN | 1982-01-01 | 1 products, RLD |
| LIMBITROL DS | Chartwell Pharmaceuticals | N-016949 DISCN | 1982-01-01 | 1 products, RLD |
Brand Name | Status | Last Update |
|---|---|---|
| amitriptyline | ANDA | 2009-10-22 |
| amitriptyline hcl | ANDA | 2025-05-13 |
| amitriptyline hydrochloride | ANDA | 2025-10-04 |
| chlordiazepoxide & amitriptyline hydrochloride | 2007-02-12 | |
| chlordiazepoxide and amitriptyline hydrochloride | ANDA | 2025-07-07 |
| chlordiazepoxide and amitriptyline hydrochloride chlordiazepoxide and amitriptyline hydrochloride | ANDA | 2025-06-11 |
| elavil | ANDA | 2021-08-31 |
| elavil 25 mg | ANDA | 2016-04-13 |
| perphenazine and amitriptyline hydrochloride | ANDA | 2025-08-30 |
| sentravil pm-25 | unapproved drug other | 2011-08-01 |
Code | Description |
|---|---|
| J1320 | Injection, amitriptyline hcl, up to 20 mg |

Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Fibromyalgia | D005356 | EFO_0005687 | M79.1 | — | — | — | 1 | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Major depressive disorder | D003865 | EFO_0003761 | F22 | — | — | 1 | — | — | 1 |
| Drug common name | Amitriptyline |
| INN | amitriptyline |
| Description | Amitriptyline is an organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5. It has a role as an adrenergic uptake inhibitor, an antidepressant, an environmental contaminant, a xenobiotic and a tropomyosin-related kinase B receptor agonist. It is a tertiary amine and a carbotricyclic compound. It derives from a hydride of a dibenzo[a,d][7]annulene. |
| Classification | Small molecule |
| Drug class | antidepressants (dibenzol[a,d]cycloheptane derivatives) |
| Image (chem structure or protein) | ![]() |
| Structure (InChI/SMILES or Protein Sequence) | CN(C)CCC=C1c2ccccc2CCc2ccccc21 |
| PDB | — |
| CAS-ID | 50-48-6 |
| RxCUI | — |
| ChEMBL ID | CHEMBL629 |
| ChEBI ID | 2666 |
| PubChem CID | 2160 |
| DrugBank | DB00321 |
| UNII ID | 1806D8D52K (ChemIDplus, GSRS) |
















